Authors: Jiangang Pan Mo Liu Xing Zhou
Publish Date: 2014/05/08
Volume: 8, Issue: 2, Pages: 241-249
Abstract
Approximately 70 of newly diagnosed bladder tumors are nonmuscle invasive bladder cancer NMIBC NMIBC accounts for approximately 80 of total bladder cancer cases Bacillus CalmetteGuérin BCG instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC we analyzed this relationship by conducting an updated detailed metaanalysis Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC
Keywords: